Albertsons must pay $900 million for fueling opioid epidemic in Washington state, judge rules

Albertsons was ordered to pay $900 million for its role in Washington state's opioid crisis. The verdict, announced by Attorney General Nick Brown, cited the company's policies that prioritized profit over safety and led to the dispensing of 641 million opioid pills with red flags. The funds will support addiction treatment and prevention initiatives.

Albertsons Cos. was ordered to pay $900 million by a Washington state judge for contributing to the opioid epidemic. The ruling includes $800 million for opioid crisis efforts and $100 million in penalties. The judge found Albertsons failed to implement adequate safeguards and properly investigate suspicious prescriptions. Albertsons operated around 227 pharmacies in Washington at the time of the lawsuit.

Albertsons must pay Washington state $900 million for its pharmacies' role in the opioid crisis, according to a state court ruling. The judge found Albertsons failed to prevent misuse of opioids. Albertsons plans to appeal and disagrees with the ruling. The company previously reached a $774 million framework to settle national opioid claims, contributing to a $500 million net loss in Q4 2025.

A court ruled against Albertsons, awarding Washington $900 million for its role in the state's opioid crisis. The ruling found Albertsons liable for failing to prevent opioid diversion and violating consumer protection laws, according to the court.

ACI Worldwide reported a Q3 2026 revenue decline due to timing of license renewals. The company is transitioning to payments orchestration, with ACI Kinetic gaining its first live customer, Solaris, and signing a large African bank. Management is confident in meeting full-year targets, with 95% of revenue already secured. They expect meaningful revenue from Kinetic in 2027 and anticipate long-term growth driven by global payments complexity.

A judge ordered Albertsons to pay Washington $900 million for its role in the opioid crisis, citing the company's failure to prevent misuse. The funds will support treatment and prevention efforts. Albertsons plans to appeal, stating it disagrees with the ruling. The state alleges Albertsons pharmacies dispensed 641 million opioid pills with uninvestigated red flags between 2006 and 2022.